Paying users zone. Data is covered by hidden .

Abbott Laboratories (ABT)

Adjustments to Financial Statements

Difficulty: Advanced

Abbott Laboratories, adjusted current assets

USD $ in millions

		Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
	As Reported
	Current assets
	Adjustments
	Add: Allowances for doubtful accounts and product returns
	Less: Deferred income taxes¹
	After Adjustment
	Adjusted current assets

Source: Based on data from Abbott Laboratories Annual Reports

¹ Deferred income taxes. See Details »

Abbott Laboratories, adjusted total assets

USD $ in millions

		Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
	As Reported
	Total assets
	Adjustments
	Add: Operating leased assets¹
	Add: Allowances for doubtful accounts and product returns
	Less: Deferred income taxes²
	After Adjustment
	Adjusted total assets

Source: Based on data from Abbott Laboratories Annual Reports

¹ Operating leased assets. See Details »

² Deferred income taxes. See Details »

Abbott Laboratories, adjusted total liabilities

USD $ in millions

		Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
	As Reported
	Total liabilities
	Adjustments
	Add: Operating lease obligations¹
	Less: Deferred income taxes²
	Less: Restructuring Plans, accrued balance
	After Adjustment
	Adjusted total liabilities

Source: Based on data from Abbott Laboratories Annual Reports

¹ Operating lease obligations. See Details »

² Deferred income taxes. See Details »

Abbott Laboratories, adjusted total shareholders' investment

USD $ in millions

		Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
	As Reported
	Total Abbott shareholders' investment
	Adjustments
	Less: Net deferred tax assets (liabilities)¹
	Add: Allowances for doubtful accounts and product returns
	Add: Restructuring Plans, accrued balance
	Add: Noncontrolling interests in subsidiaries
	After Adjustment
	Adjusted total shareholders' investment

Source: Based on data from Abbott Laboratories Annual Reports

¹ Net deferred tax assets (liabilities). See Details »

Abbott Laboratories, adjusted capitalization table

USD $ in millions

		Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
	As Reported
	Short-term borrowings
	Current portion of long-term debt
	Long-term debt, excluding current portion
	Total reported debt
	Total Abbott shareholders' investment
	Total reported capital
	Adjustments to Debt
	Add: Operating lease obligations¹
	Adjusted total debt
	Adjustments to Equity
	Less: Net deferred tax assets (liabilities)²
	Add: Allowances for doubtful accounts and product returns
	Add: Restructuring Plans, accrued balance
	Add: Noncontrolling interests in subsidiaries
	Adjusted total shareholders' investment
	After Adjustment
	Adjusted total capital

Source: Based on data from Abbott Laboratories Annual Reports

¹ Operating lease obligations. See Details »

² Net deferred tax assets (liabilities). See Details »

Abbott Laboratories, adjusted comprehensive income (loss)

USD $ in millions

	12 months ended	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013
	As Reported
	Net earnings
	Adjustments
	Add: Deferred income tax expense (benefit)¹
	Add: Increase (decrease) in allowances for doubtful accounts and product returns
	Add: Increase (decrease) in restructuring Plans, accrued balance
	Less: Net earnings from discontinued operations, net of taxes
	Add: Other comprehensive income (loss)
	After Adjustment
	Adjusted comprehensive income (loss)

Source: Based on data from Abbott Laboratories Annual Reports

¹ Deferred income tax expense (benefit). See Details »

	Abbott Laboratories	Other companies (not purchased previously)
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality

	All companies
Financial Statements
Common-Size Financial Statements
Ratios
Relative Valuation
Discounted Cash Flow (DCF) Valuation
Economic Value Added (EVA)
Long-term Trends
Analysis
Financial Reporting Quality